Immunotech Biopharm Ltd (HKG:6978)
Hong Kong
· Delayed Price · Currency is HKD 2.450
+0.090 (3.81%)
At close: Mar 10, 2026
Immunotech Biopharm Market Cap
Immunotech Biopharm has a market cap or net worth of 1.46 billion as of March 10, 2026. Its market cap has increased by 10.63% in one year.
Market Cap
1.46B
Enterprise Value
1.90B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.45
Market Cap Chart
Since July 10, 2020, Immunotech Biopharm's market cap has decreased from 7.74B to 1.46B, a decrease of -81.17%. That is a compound annual growth rate of -25.53%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 1.44B |
| CANbridge Pharmaceuticals | 1.39B |
| HighTide Therapeutics | 1.37B |
| Beijing Biostar Pharmaceuticals | 1.37B |
| Mabpharm | 1.69B |
| Cutia Therapeutics | 1.71B |
| Shanghai Bio-heart Biological Technology | 1.20B |
| Zhaoke Ophthalmology | 1.85B |